Speaker illustration

undefined undefined undefined

Global assessment of cardiovascular risk prediction tools: Analysis of over 10 million individuals from international cohorts and trials

Event: ESC Congress 2025

Topic: Cardiovascular Risk Assessment

Session: Risk factors and prevention

Thumbnail

Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial

Event: ESC Congress 2024

Topic: Renal Failure and Cardiovascular Disease

Session: Young Investigator Award Session in Preventive Cardiology

Thumbnail

Natriuretic peptides, kidney function and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: pooled data from the I-PRESERVE, TOPCAT, PARAGON and DELIVER trials

Event: ESC Congress 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Diagnostic accuracy of natriuretic peptides

Thumbnail

Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: Insights from the CREDENCE trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Congress committee e-posters choice in preventive cardiology and special populations

Thumbnail

ESC 365 is supported by